Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of Migraine
Public ClinicalTrials.gov record NCT02638103. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of Migraine
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous (SC) administration of TEV-48125 in adult participants with chronic migraine (CM) or episodic migraine (EM). Participants with CM or EM who complete the pivotal efficacy studies of TEV-48125 (TV48125-CNS-30049 \[NCT02621931\] and TV48125-CNS-30050 \[NCT02629861\]) and agree to participate in this study; and new participants meeting eligibility criteria (not rolling over from pivotal studies), will be enrolled in this study.
Study identification
- NCT ID
- NCT02638103
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,890 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 26, 2016 (Actual)
- Primary completion
- Jun 6, 2018 (Actual)
- Completion
- Dec 8, 2018 (Actual)
- Last update posted
- Nov 9, 2021
2016 – 2018
United States locations
- U.S. sites
- 90
- U.S. states
- 37
- U.S. cities
- 78
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 13628 | Birmingham | Alabama | 35211 | — |
| Teva Investigational Site 13577 | Birmingham | Alabama | 35216 | — |
| Teva Investigational Site 13606 | Phoenix | Arizona | 85018 | — |
| Teva Investigational Site 13579 | Phoenix | Arizona | 85023 | — |
| Teva Investigational Site 13602 | Little Rock | Arkansas | 72205 | — |
| Teva Investigational Site 13568 | Encino | California | 91316 | — |
| Teva Investigational Site 13546 | Fullerton | California | 92835 | — |
| Teva Investigational Site 13540 | Long Beach | California | 90806 | — |
| Teva Investigational Site 13632 | Redlands | California | 92374 | — |
| Teva Investigational Site 13571 | Redondo Beach | California | 90277 | — |
| Teva Investigational Site 13573 | San Diego | California | 92103 | — |
| Teva Investigational Site 13538 | Santa Monica | California | 90404 | — |
| Teva Investigational Site 13594 | Santa Rosa | California | 95405 | — |
| Teva Investigational Site 13595 | Walnut Creek | California | 94598 | — |
| Teva Investigational Site 13629 | Aurora | Colorado | 80014 | — |
| Teva Investigational Site 13557 | Boulder | Colorado | 80301 | — |
| Teva Investigational Site 13593 | Colorado Springs | Colorado | 80918 | — |
| Teva Investigational Site 13633 | Denver | Colorado | 80210 | — |
| Teva Investigational Site 13612 | Denver | Colorado | 80239 | — |
| Teva Investigational Site 13631 | Englewood | Colorado | 80113 | — |
| Teva Investigational Site 13563 | East Hartford | Connecticut | 06118 | — |
| Teva Investigational Site 13550 | Stamford | Connecticut | 06905 | — |
| Teva Investigational Site 13635 | Bradenton | Florida | 34201 | — |
| Teva Investigational Site 13597 | Gainesville | Florida | 32607 | — |
| Teva Investigational Site 13607 | Hialeah | Florida | 33012 | — |
| Teva Investigational Site 13559 | Jacksonville | Florida | 32205 | — |
| Teva Investigational Site 13584 | Ocala | Florida | 34471 | — |
| Teva Investigational Site 13587 | Orlando | Florida | 32806 | — |
| Teva Investigational Site 13567 | Palm Beach Gardens | Florida | 33410 | — |
| Teva Investigational Site 13553 | Pembroke Pines | Florida | 33026 | — |
| Teva Investigational Site 13616 | Pinellas Park | Florida | 33781 | — |
| Teva Investigational Site 13620 | Atlanta | Georgia | 30312 | — |
| Teva Investigational Site 13537 | Atlanta | Georgia | 30342 | — |
| Teva Investigational Site 13604 | Boise | Idaho | 83642 | — |
| Teva Investigational Site 13585 | Chicago | Illinois | 60607 | — |
| Teva Investigational Site 13621 | Chicago | Illinois | 60654 | — |
| Teva Investigational Site 13627 | Evanston | Illinois | 60201 | — |
| Teva Investigational Site 13596 | Indianapolis | Indiana | 46254 | — |
| Teva Investigational Site 13617 | Wichita | Kansas | 67207 | — |
| Teva Investigational Site 13598 | Wichita | Kansas | 67211 | — |
| Teva Investigational Site 13566 | Louisville | Kentucky | 40207 | — |
| Teva Investigational Site 13603 | Metairie | Louisiana | 70006 | — |
| Teva Investigational Site 13582 | Pikesville | Maryland | 21208 | — |
| Teva Investigational Site 13590 | Boston | Massachusetts | 02131 | — |
| Teva Investigational Site 13589 | New Bedford | Massachusetts | 02301 | — |
| Teva Investigational Site 13543 | Watertown | Massachusetts | 02472 | — |
| Teva Investigational Site 13539 | Ann Arbor | Michigan | 48104 | — |
| Teva Investigational Site 13542 | Golden Valley | Minnesota | 55422 | — |
| Teva Investigational Site 13534 | Kansas City | Missouri | 64114 | — |
| Teva Investigational Site 13536 | Springfield | Missouri | 65807 | — |
| Teva Investigational Site 13619 | St Louis | Missouri | 63141 | — |
| Teva Investigational Site 13618 | Fremont | Nebraska | 68025 | — |
| Teva Investigational Site 13605 | Las Vegas | Nevada | 89106 | — |
| Teva Investigational Site 13578 | Lebanon | New Hampshire | 03756 | — |
| Teva Investigational Site 13575 | Martinsville | New Jersey | 08836 | — |
| Teva Investigational Site 13622 | Princeton | New Jersey | 08540 | — |
| Teva Investigational Site 13588 | Albuquerque | New Mexico | 87102 | — |
| Teva Investigational Site 13576 | Amherst | New York | 14226 | — |
| Teva Investigational Site 13565 | Plainview | New York | 11803 | — |
| Teva Investigational Site 13544 | Greensboro | North Carolina | 27405 | — |
| Teva Investigational Site 13574 | Greensboro | North Carolina | 27408 | — |
| Teva Investigational Site 13545 | Raleigh | North Carolina | 27612 | — |
| Teva Investigational Site 13609 | Akron | Ohio | 44311 | — |
| Teva Investigational Site 13625 | Akron | Ohio | 44311 | — |
| Teva Investigational Site 13634 | Akron | Ohio | 44311 | — |
| Teva Investigational Site 13533 | Cincinnati | Ohio | 45227 | — |
| Teva Investigational Site 13624 | Cincinnati | Ohio | 45249 | — |
| Teva Investigational Site 13569 | Cleveland | Ohio | 44195 | — |
| Teva Investigational Site 13626 | Columbus | Ohio | 43212 | — |
| Teva Investigational Site 13561 | Oklahoma City | Oklahoma | 73112 | — |
| Teva Investigational Site 13601 | Eugene | Oregon | 97401 | — |
| Teva Investigational Site 13591 | Jenkintown | Pennsylvania | 19046 | — |
| Teva Investigational Site 13554 | Philadelphia | Pennsylvania | 19107 | — |
| Teva Investigational Site 13608 | Uniontown | Pennsylvania | 15401 | — |
| Teva Investigational Site 13615 | Greer | South Carolina | 29650 | — |
| Teva Investigational Site 13556 | Mt. Pleasant | South Carolina | 29464 | — |
| Teva Investigational Site 13560 | Bristol | Tennessee | 37620 | — |
| Teva Investigational Site 13551 | Memphis | Tennessee | 38119 | — |
| Teva Investigational Site 13532 | Nashville | Tennessee | 37203 | — |
| Teva Investigational Site 13552 | Nashville | Tennessee | 37203 | — |
| Teva Investigational Site 13541 | Austin | Texas | 78731 | — |
| Teva Investigational Site 13623 | Dallas | Texas | 75214 | — |
| Teva Investigational Site 13611 | Plano | Texas | 75024 | — |
| Teva Investigational Site 13572 | San Antonio | Texas | 78229 | — |
| Teva Investigational Site 13614 | Murray | Utah | 84107 | — |
| Teva Investigational Site 13581 | West Jordan | Utah | 84088 | — |
| Teva Investigational Site 13630 | Virginia Beach | Virginia | 23454 | — |
| Teva Investigational Site 13564 | Seattle | Washington | 98105 | — |
| Teva Investigational Site 13586 | Seattle | Washington | 98105 | — |
| Teva Investigational Site 13600 | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02638103, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 9, 2021 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02638103 live on ClinicalTrials.gov.